Top 10 Recent Advances in Veterinary Oncology

Philip Bergman, DVM, MS, PhD, DACVIM

Dr. Bergman is the Director of Clinical Studies for Mars Veterinary Health. He is the principal veterinary investigator for the fully licensed canine melanoma vaccine (Oncept). Dr. Bergman is an adjunct faculty member of the Memorial Sloan-Kettering Cancer Center. Prior to Dr. Bergman joining VCA, he served as the Chief Medical Officer for BrightHeart Veterinary Centers from July 2007 to August 2011; from 1999 to June 2007 he was the head of the Donaldson-Atwood Cancer Center at AMC. After finishing veterinary school from Colorado State in 1990, he was an intern at Kansas State (90-91) and returned to CSU for his medical oncology residency (91-94) and then completed a PhD Fellowship in human cancer biology from the M.D. Anderson Cancer Center in Houston (94-99). He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society. Dr. Bergman has been an veterinary oncologist at Katonah Bedford Veterinary Center since 2007.

Overview:

Many clients with pets expect the same level of care from their veterinarians as they expect for themselves from their physician. This is especially true for clients with pets, which have cancer. In order to provide this level of care, one must understand and employ the recent advances in medical, surgical and radiation oncology that will be presented in this discussion.

Learning Objectives:

Become more fluent in the latest advancements in veterinary oncology
Understand the impact of CT scans for staging compared to traditional 3 view chest Xrays
Better understand the mechanisms of action and side effects of the latest oncology therapeutics
Become more fluent in the details of anti-emetics in physician-based vs veterinary-based oncology care

This course is RACE-approved for 1.0 continuing education credits hours in jurisdictions that accept RACE-approval.

This activity is sponsored by Volition Veterinary.